Dr. David Ryan Lally , MD
Ophthalmology • Springfield, MA
3640 Main St, Ste 201
Springfield, MA 011071145
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 7, 2009; this date does not establish years in practice.
-
Published CMS data list 52,201 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 — Injection, faricimab-svoa, 0.1 mg: 39,240 service units.
- 92134 — Imaging of retina: 2,641 service units.
- 67028 — Injection of drug into eye: 2,039 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 19 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 467 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisolone Acetate — 172 prescription fills, including refills.
- Ofloxacin — 82 prescription fills, including refills.
- Latanoprost — 53 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 10 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: 7,071. Middle half: 3,838 to 24,877.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: 1,836. Middle half: 620 to 3,509.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 13,052 in 2020 to 52,201 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
3640 Main St
Ste 201
Springfield, MA 011071145
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: New England Retina Consultants, Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2009
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
849 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $4,487,139 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $3,530,703 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
702 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$15,235 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $38,319.29 across 42 records.
By nature of payment (3 largest of 4)
- Consulting Fee: $23,958.81 across 11 records.
- Travel and Lodging: $12,299.95 across 6 records.
- Food and Beverage: $1,724.01 across 24 records.
Reporting-company totals (3 largest of 11)
- Boehringer Ingelheim International GmbH: $13,960.00 across 5 records.
- Astellas Pharma Global Development: $9,150.52 across 6 records.
- Ocular Therapeutix, Inc.: $7,727.03 across 11 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
17 years (graduated 2009)
CMS Doctors and Clinicians data list 2009 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2009
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Lally has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Lally as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Springfield and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: 7,071. Middle half: 3,838 to 24,877.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: 1,836. Middle half: 620 to 3,509.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: $597,301. Middle half: $458,560 to $2,843,201.
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: $194,367. Middle half: $57,908 to $416,629.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: $431,741. Middle half: $334,497 to $2,231,796.
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: $144,463. Middle half: $40,965 to $304,911.
Medicare Part D prescriptions
Fewer Part D prescriptions than 80% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: 1,592. Middle half: 553 to 4,285.
Fewer Part D prescriptions than 60% of clinicians listed under Ophthalmology in Massachusetts (2024, 517 clinicians with data). Median for this group: 764. Middle half: 219 to 2,063.
Part D drug cost
A lower Part D drug cost than 70% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: $152,725. Middle half: $13,557 to $532,270.
A lower Part D drug cost than 65% of clinicians listed under Ophthalmology in Massachusetts (2024, 517 clinicians with data). Median for this group: $61,248. Middle half: $7,840 to $214,090.
17 active clinicians are listed under Ophthalmology with a practice address in Springfield, MA (792 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Springfield
0% of these 17 clinicians have the CMS telehealth indicator.
64.7% of these 17 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 300% from 13,052 in 2020 to 52,201 in 2024.
- 2020: 13,052
- 2021: 9,902
- 2022: 13,875
- 2023: 31,227
- 2024: 52,201
-
Medicare-allowed amount
Medicare-allowed amount increased 40% from $3,205,548 in 2020 to $4,487,139 in 2024.
- 2020: $3,205,548
- 2021: $2,870,674
- 2022: $3,020,192
- 2023: $4,028,938
- 2024: $4,487,139
-
Paid by Medicare
Paid by Medicare increased 40% from $2,524,260 in 2020 to $3,530,703 in 2024.
- 2020: $2,524,260
- 2021: $2,285,108
- 2022: $2,373,179
- 2023: $3,166,742
- 2024: $3,530,703
-
Medicare Part D prescriptions
Medicare Part D prescriptions varied from year to year: 492 in 2020 and 467 in 2024.
- 2020: 492
- 2021: 358
- 2022: 466
- 2023: 450
- 2024: 467
-
30-day fills
30-day fills increased 12% from 624 in 2020 to 702 in 2024.
- 2020: 624
- 2021: 457
- 2022: 613
- 2023: 593
- 2024: 702
-
Part D drug cost
Part D drug cost decreased 14% from $17,617 in 2020 to $15,235 in 2024.
- 2020: $17,617
- 2021: $13,506
- 2022: $12,606
- 2023: $14,409
- 2024: $15,235
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 24% from $30,785.80 in 2021 to $38,319.29 in 2025.
- 2021: $30,785.80
- 2022: $54,364.00
- 2023: $48,024.31
- 2024: $34,340.60
- 2025: $38,319.29
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 42 records totaling $38,319.29.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Boehringer Ingelheim International GmbH |
Travel and Lodging
In-kind items and services
|
— | General | $7,125.00 |
| Astellas Pharma Global Development |
Consulting Fee
Cash or cash equivalent
|
Izervay | General | $4,000.00 |
| Boehringer Ingelheim International GmbH |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,800.00 |
| Astellas Pharma Global Development |
Travel and Lodging
Cash or cash equivalent
|
Izervay | General | $3,157.40 |
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
EYLEA HD | General | $2,350.00 |
| Neurotech Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,078.81 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,000.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,000.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,000.00 |
| Boehringer Ingelheim International GmbH |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,900.00 |
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
EYLEA HD | General | $1,880.00 |
| Astellas Pharma Global Development |
Travel and Lodging
Cash or cash equivalent
|
Izervay | General | $1,790.66 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,000.00 |
| Boehringer Ingelheim International GmbH |
Consulting Fee
Cash or cash equivalent
|
— | General | $950.00 |
| Alcon Vision LLC |
Long term medical supply or device loan
In-kind items and services
|
UNITY | General | $336.52 |
| Ocular Therapeutix, Inc. |
Food and Beverage
In-kind items and services
|
DEXTENZA | General | $225.06 |
| Boehringer Ingelheim International GmbH |
Travel and Lodging
In-kind items and services
|
— | General | $185.00 |
| Ocular Therapeutix, Inc. |
Food and Beverage
In-kind items and services
|
DEXTENZA | General | $164.38 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $143.92 |
| Ocular Therapeutix, Inc. |
Food and Beverage
In-kind items and services
|
DEXTENZA | General | $126.70 |
| Astellas Pharma Global Development |
Food and Beverage
In-kind items and services
|
Izervay | General | $125.00 |
| Ocular Therapeutix, Inc. |
Food and Beverage
In-kind items and services
|
DEXTENZA | General | $124.56 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $113.03 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $109.42 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $75.31 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
39,240 | 116 | $40.00 | $34.60 |
|
92134
Imaging of retina
|
2,641 | 790 | $99.92 | $40.97 |
|
67028
Injection of drug into eye
|
2,039 | 453 | $568.29 | $128.80 |
|
J0177
Injection, aflibercept hd, 1 mg
|
1,672 | 54 | $375.00 | $331.72 |
|
J0178
Injection, aflibercept, 1 mg
|
1,668 | 172 | $1050.00 | $823.73 |
|
J2781
Injection, pegcetacoplan, intravitreal, 1 mg
|
1,395 | 17 | $170.00 | $131.15 |
|
J2778
Injection, ranibizumab, 0.1 mg
|
1,130 | 47 | $420.00 | $157.20 |
|
92014
Established patient complete exam of visual system
|
622 | 529 | $285.00 | $127.54 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
404 | 313 | $140.00 | $91.87 |
|
J9035
Injection, bevacizumab, 10 mg
|
320 | 84 | $200.00 | $71.32 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
306 | 235 | $210.00 | $129.63 |
|
J7312
Injection, dexamethasone, intravitreal implant, 0.1 mg
|
245 | 16 | $215.00 | $202.31 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
187 | 138 | $90.00 | $56.91 |
|
92004
New patient complete exam of visual system
|
111 | 111 | $300.00 | $151.34 |
|
J3590
Unclassified biologics
|
82 | 47 | $2908.54 | $2422.06 |
|
92250
Photography of the retina
|
68 | 64 | $297.79 | $36.59 |
|
76512
2d ultrasound scan of eye tissue and structures
|
31 | 24 | $521.45 | $52.91 |
|
67228
Destruction of leaking blood vessels of retina using laser
|
23 | 13 | $2000.00 | $341.50 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
17 | 17 | $300.00 | $168.79 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone Acetate | 172 | 5,640 | $7,133.03 | 87 |
| Ofloxacin | Ofloxacin | 82 | 2,821 | $1,470.96 | 63 |
| Latanoprost | Latanoprost | 53 | 2,773 | $525.06 | 23 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 31 | 1,098 | $603.69 | 14 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 26 | 2,309 | $457.00 | 18 |
| Brimonidine Tartrate | Brimonidine Tartrate | 22 | 1,053 | $1,450.82 | 16 |
| Dorzolamide Hcl | Dorzolamide Hcl | 21 | 1,295 | $479.91 | — |
| Atropine Sulfate | Atropine Sulfate | 21 | 962 | $760.07 | 11 |
| Difluprednate | Difluprednate | 21 | 393 | $2,083.06 | — |
| Timolol Maleate | Timolol Maleate | 18 | 1,421 | $271.12 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-12-19NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20130822000018
MA
3971746959
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
New England Retina Consultants, Pc
3640 Main St, Springfield, MA 011071139
Phone: 4137322333
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology - Retina Specialist
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 3640 MAIN ST STE 201, SPRINGFIELD, MA 011071139 (Tel: 4137322333)
Ophthalmology (license number reported to NPPES: MA 254315)
NPI status registered as active in NPPES database
Registered at 3640 MAIN ST, STE 201, SPRINGFIELD, MA 011071145 (Tel: 4137322333)
Registered at 3640 MAIN ST, STE 201, SPRINGFIELD, MA 011071145 (Tel: 4137322333)
Recorded as DAVID LALLY, M.D.
Internal Medicine (license number reported to NPPES: OH 57.016146)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Springfield
- Dr. Ronald Gailun, MD
- Dr. Steven Berger, MD
- Dr. David Agahigian, MD
- Dr. Hari Mylvaganam, MD
- Dr. Andrew Jusko, MD
- Dr. Elizabeth Arsenio, MD
Mailing Address
3640 Main St Ste 201
Springfield, MA 011071139
Phone: 4137322333